当前位置:

网站首页>文章详情

糖原合成激酶-3在心血管疾病中的研究进展

【PDF在线阅读】 【下载PDF】
  • Author:

  • 作者单位:

  • Author Unit:

  • 关键词:

  • Keywords:

  • 中图分类号:

  • R541

摘要:

Abstract:

基金项目:

参考文献:

[1] Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A[J]. EMBO J,1990,9(8):2431-8.

[2] Hughes K,Nikolakaki E,Plyte SE,et al. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation[J]. EMBO J,1993,12(2):803-8.

[3] Lochhead PA,Kinstrie R,Sibbet G,et al. A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation[J]. Mol Cell,2006,24(4):627-33.

[4] Kirk JA,Holewinski RJ,Kooij V,et al. Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β[J]. J Clin Invest,2014,124(1):129-38.

[5] Thornton TM,Pedraza-Alva G,Deng B,et al. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation[J]. Science, 2008,320(5876):667-70.

[6] Matsuda T,Zhai P,Maejima Y,et al. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload[J]. Proc Natl Acad Sci USA,2008,105(52):20900-5.

[7] Antos CL,McKinsey TA,Frey N,et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo[J]. Proc Natl Acad Sci USA,2002,99(2):907-12.

[8] Gomez L,Paillard M,Thibault H,et al. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion[J]. Circulation,2008,117(21):2761-8.

[9] Nishino Y,Webb IG,Davidson SM,et al. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse[J]. Circ Res,2008,103(3):307-14.

[10] Haq S,Choukroun G,Kang ZB,et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy[J]. J Cell Biol,2000,151(1):117-30.

[11] Zhou J,Lal H,Chen X,et al. GSK-3alpha directly regulates betaadrenergic signaling and the response of the heart to hemodynamic stress in mice[J]. J Clin Invest,2010,120(7):2280-91.

[12] Lal H,Zhou J,Ahmad F,et al. Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death[J]. Circulation,2012,125(1):65-75.

[13] Zhou J,Freeman TA,Ahmad F,et al. GSK-3α is a central regulator of age-related pathologies in mice[J]. J Clin Invest,2013,123(4):1821-32.

[14] Lal H,Ahmad F,Zhou J,et al. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart[J]. Circulation,2014,130(5):419-30.

[15] Kerkela R,Kockeritz L,Macaulay K,et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary t o c a r d i o m y o b l a s t h y p e r p r o l i f e r a t i o n [ J ] . J C l i n I n v e s t , 2008,118(11):3609-18.

[16] Force T,Woodgett JR. Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development[J]. J Biol Chem,2009,284(15):9643-47.

[17] Zhai P,Gao S,Holle E,et al. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overloadinduced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases[J]. J Biol Chem, 2007,282(45):33181-91.

[18] Ahmad F,Lal H,Zhou J,et al. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure[J]. J Am Coll Cardiol,2014,64(7):696-706.

[19] Porrello ER,Mahmoud AI,Simpson E,et al. Transient regenerative potential of the neonatal mouse heart[J]. Science,2011,331(6020): 1078-80.

[20] Leri A,Kajstura J,Anversa P. Mechanisms of myocardial regeneration[J]. Trends Cardiovasc Med,2011,21(2):52-8.

[21] Bergmann O,Bhardwaj RD,Bernard S,et al. Evidence for cardiomyocyte renewal in humans[J]. Science,2009,324(5923):98-102.

[22] Kajstura J,Urbanek K,Rota M,et al. Cardiac stem cells and myocardial disease[J]. J Mol Cell Cardiol,2008,45(4):505-13.

[23] Laflamme MA,Murry CE. Regenerating the heart[J]. Nat Biotechnol,2005,23(7):845-56.

[24] Chiong M,Wang ZV,Pedrozo Z,et al. Cardiomyocyte death:mechanisms and translational implications[J]. Cell Death Dis,2011,2(12):e244-76.

[25] Doble BW,Patel S,Wood GA,et al. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines[J]. Dev Cell,2007,12(6):957-71

[26] Morisco C,Zebrowski D,Condorelli G,et al. The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes[J]. J Biol Chem,2000,275(19):14466-75.

[27] Michael A,Haq S,Chen X,et al. Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart[J]. J Biol Chem,2004,279(20):21383-93.

[28] Woulfe KC,Gao E,Lal H,et al. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress induced cardiomyocyte proliferation in vivo[J]. Circ Res,2010,106(10):1635-45.

[29] Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases[J]. J Clin Invest,2007,117(3):524-9.

[30] Chen W,Frangogiannis NG. Fibroblasts in post-infarction inflammation and cardiac repair[J]. Biochim Biophys Acta,2013,1833(4):945-53.

[31] Takeda N,Manabe I,Uchino Y,et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload[J]. J Clin Invest,2010,120(1):254-65.

[32] Duan J,Gherghe C,Liu D,et al. Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair[J]. EMBO J,2012,31(2):429-42.

[33] Bergmann C,Akhmetshina A,Dees C,et al. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway[J]. Ann Rheum Dis,2011,70(12):2191-8.

[34] Caraci F,Gili E,Calafiore M,et al. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts[J]. Pharmacol Res,2008,57(4):274-82.

[35] Rao TP,Ku?hl M. An updated overview on Wnt signaling pathways: a prelude for more[J]. Circ Res,2010,106(12):1798-806.

[36] Schmierer B,Tournier AL,Bates PA,et al. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal interpreting system[J]. Proc Natl Acad Sci USA,2008,105(18):6608-13.

[37] Guo X,Ramirez A,Waddell DS,et al. Axin and GSK3-control Smad3 protein stability and modulate TGF- signaling[J]. Genes Dev,2008,22(1):106-20.

  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com